在冠状动脉疾病中潜在的昼夜节律相关的致病基因:孟德尔随机化研究
Hongliang Zhang1, Zhenyan Zhao1, Wence Shi1
1Coronary Heart Disease Center, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, National Center for Cardiovascular Diseases, Beilishi Road 167, Xicheng District, Beijing 100037, China.
循环节律基因RASD1和SREBF1与冠状动脉疾病 (CAD) 的发病有因果关系. 这项孟德尔随机化研究强调了它们作为CAD预防和治疗的治疗点的潜力.
科学领域:
- 遗传学
- 心血管疾病
- 时间生物学
背景情况:
- 冠状动脉疾病 (CAD) 是全球的主要健康问题.
- 昼夜节律的障碍越来越多地与CAD的发展有关.
- 这种关联的确切遗传机制需要进一步阐明.
研究的目的:
- 研究昼夜节律基因在冠状动脉疾病 (CAD) 中的因果作用.
- 探索这些遗传关联的临床影响.
- 确定潜在的治疗点.
主要方法:
- 使用基于总结数据的门德尔随机化.
- 对CAD的全基因组关联研究 (GWAS) 数据与昼夜节律基因信息相结合.
- 使用表达量特征位点 (eQTL),甲基化量特征位点 (mQTL) 和蛋白质丰度量特征位点 (pQTL) 数据进行因果推断.
- 地方化分析证实了基因变异的起源.
主要成果:
- 发现13个甲基化位点和8个关键的昼夜节律基因与CAD有因果关系.
- 发现RASD1和SREBF1是特别重要的基因.
- 对RASD1和SREBF1分别确定了与CAD风险的特异性表观遗传 (cg20122488甲基化) 和转录调节关系.
结论:
- 循环节律基因,特别是RASD1和SREBF1,在CAD的发病过程中起着重要作用.
- 这些基因代表了新的CAD预防和治疗策略的有希望的治疗点.
- 需要进一步的研究来验证这些发现,并开发基于昼夜的干预措施.
更多相关视频
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
相关概念视频
Circadian Rhythms and Gene Regulation
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Regulation of Heart Rates
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
